REM sleep behavior disorder: Is it useful to differentiate between Parkinson disease and Progressive Supranuclear Palsy?
Objective: To determine the prevalence of rapid eye movement (REM) sleep behavior disorder (RBD) in autopsy confirmed Parkinson disease (PD) and Progressive Supranuclear Palsy (PSP).…Use of the Neuropsychiatric Inventory to Characterize the Course of Neuropsychiatric Symptoms in Progressive Supranuclear Palsy
Objective: The aim of this study was to determine the neuropsychiatric profile in our cohort of PSP patients and their dynamic changes over a follow-up…Effect of low frequency stimulation on freezing of gait in a PSP patient with bilateral STN DBS
Objective: To study the effect of low frequency stimulation (LFS) on freezing of gait (FOG) in a progressive supranuclear palsy (PSP) patient with bilateral STN…Tyrosine kinase inhibition clears Tau and reserves neuropathology and motor symptoms in a novel model of progressive supranuclear palsy
Objective: Our objective was to examine the effects of tau accumulation in transgenic mice, observing both motor function and behavior. Background: Tau hyper-phosphorylation is a…Dysphagia in PSP
Objective: To characterize the nature of dysphagia accompanying progressive supranuclear palsy (PSP). Background: Dysphagia is a frequent symptom of PSP, typically occurring early in the…Levodopa induced dyskinesia in a case of progressive supranuclear palsy.
Objective: We describe the mechanism of dyskinesia in patients with progressive supranuclear palsy (PSP). Background: Levodopa generally shows a poor effect to parkinsonism in patients…Which clinical features predict progressive supranuclear palsy pathology? A clinicopathological study on 437 autopsy cases and a literature review
Objective: To identify clinical features and investigations which predict PSP pathology during lifetime in the largest pathology PSP cohort reported to date compared to autopsy…The phenotypic spectrum of patients with progressive supranuclear palsy
Objective: The aim of the this study to evaluate different modes of (initial) clinic type of patients with PSP. Background: Progressive supranuclear palsy (PSP) is…Phenotypic Heterogeneity in PSP Variants – A Case Series
Objective: To present the phenotypic heterogeneity we observed in 5 PSP variants. Background: Progressive supranuclear palsy (PSP) is a primary tauopathy characterised by progressive gait…[11C]PK11195 PET in Alzheimer’s disease and progressive supranuclear palsy: the NIMROD study
Objective: Here we test whether the intensity and regional distribution of neuro-inflammation differs between Alzheimer's disease (AD), Progressive Supranuclear Palsy (PSP) and controls; and whether neuro-inflammation…
- « Previous Page
- 1
- …
- 34
- 35
- 36
- 37
- 38
- …
- 42
- Next Page »